ETF Holdings Breakdown of MNKD

Stock NameMannKind Corp
TickerMNKD(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS56400P7069
LEI213800GFBCNY1ZFST722

News associated with MNKD

Analysts Set MannKind Co. (NASDAQ:MNKD) PT at $9.56
Shares of MannKind Co. (NASDAQ:MNKD – Get Free Report) have been assigned an average rating of “Buy” from the nine research firms that are presently covering the firm, Marketbeat Ratings reports. Seven equities research analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The […] - 2025-05-08 05:52:55
MannKind Co. (NASDAQ:MNKD) Stock Position Lifted by Barclays PLC
Barclays PLC lifted its holdings in MannKind Co. (NASDAQ:MNKD – Free Report) by 6.2% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 552,143 shares of the biopharmaceutical company’s stock after purchasing an additional 32,278 shares during the quarter. Barclays PLC owned 0.20% of […] - 2025-04-29 08:50:50
Legal & General Group Plc Lowers Position in MannKind Co. (NASDAQ:MNKD)
Legal & General Group Plc trimmed its stake in MannKind Co. (NASDAQ:MNKD – Free Report) by 3.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 337,290 shares of the biopharmaceutical company’s stock after selling 11,167 shares during the period. Legal & […] - 2025-04-25 08:42:57
Invesco Ltd. Lowers Stock Position in MannKind Co. (NASDAQ:MNKD)
Invesco Ltd. lessened its stake in MannKind Co. (NASDAQ:MNKD – Free Report) by 27.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,220,835 shares of the biopharmaceutical company’s stock after selling 464,293 shares during the period. Invesco Ltd. […] - 2025-04-25 07:58:49
Russell Investments Group Ltd. Sells 190,563 Shares of MannKind Co. (NASDAQ:MNKD)
Russell Investments Group Ltd. trimmed its position in MannKind Co. (NASDAQ:MNKD – Free Report) by 31.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 421,659 shares of the biopharmaceutical company’s stock after selling 190,563 shares during the period. Russell […] - 2025-04-18 07:50:56
MannKind Co. (NASDAQ:MNKD) Shares Bought by Geode Capital Management LLC
Geode Capital Management LLC grew its position in shares of MannKind Co. (NASDAQ:MNKD – Free Report) by 0.6% in the 4th quarter, HoldingsChannel.com reports. The fund owned 6,374,274 shares of the biopharmaceutical company’s stock after purchasing an additional 35,346 shares during the quarter. Geode Capital Management LLC’s holdings in MannKind were worth $40,996,000 as of […] - 2025-04-16 07:40:56
Cibc World Markets Corp Invests $162,000 in MannKind Co. (NASDAQ:MNKD)
Cibc World Markets Corp bought a new stake in MannKind Co. (NASDAQ:MNKD – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 25,204 shares of the biopharmaceutical company’s stock, valued at approximately $162,000. Other hedge funds have […] - 2025-03-27 09:08:51
MannKind Co. (NASDAQ:MNKD) Stake Lifted by Sequoia Financial Advisors LLC
Sequoia Financial Advisors LLC grew its holdings in shares of MannKind Co. (NASDAQ:MNKD – Free Report) by 162.8% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 50,514 shares of the biopharmaceutical company’s stock after acquiring an additional 31,294 shares during the quarter. Sequoia Financial Advisors LLC’s holdings […] - 2025-03-20 07:48:50
Victory Capital Management Inc. Purchases 171,537 Shares of MannKind Co. (NASDAQ:MNKD)
Victory Capital Management Inc. raised its position in MannKind Co. (NASDAQ:MNKD – Free Report) by 358.6% during the 4th quarter, HoldingsChannel reports. The fund owned 219,367 shares of the biopharmaceutical company’s stock after buying an additional 171,537 shares during the quarter. Victory Capital Management Inc.’s holdings in MannKind were worth $1,411,000 as of its most […] - 2025-03-19 08:18:56
Steward Partners Investment Advisory LLC Lowers Stake in MannKind Co. (NASDAQ:MNKD)
Steward Partners Investment Advisory LLC cut its holdings in shares of MannKind Co. (NASDAQ:MNKD – Free Report) by 54.0% during the fourth quarter, HoldingsChannel.com reports. The firm owned 12,627 shares of the biopharmaceutical company’s stock after selling 14,804 shares during the period. Steward Partners Investment Advisory LLC’s holdings in MannKind were worth $81,000 as of […] - 2025-03-18 08:11:03
MannKind To Present At Barclays Global Healthcare Conference; Webcast At 1:30 PM ET
(RTTNews) - MannKind Corp. (MNKD) will present at the Barclays 27th Annual Global Healthcare Conference, Miami. - 2025-03-12 16:29:32
Los Angeles Capital Management LLC Invests $86,000 in MannKind Co. (NASDAQ:MNKD)
Los Angeles Capital Management LLC acquired a new position in shares of MannKind Co. (NASDAQ:MNKD – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 13,318 shares of the biopharmaceutical company’s stock, valued at approximately $86,000. Several other institutional investors have […] - 2025-03-06 11:52:50
MannKind (MNKD) Q4 2024 Earnings Call Transcript
Image source: The Motley Fool. - 2025-02-27 05:30:16
MannKind (NASDAQ:MNKD) Now Covered by Wedbush
Wedbush initiated coverage on shares of MannKind (NASDAQ:MNKD – Free Report) in a report published on Monday morning, MarketBeat Ratings reports. The brokerage issued an outperform rating and a $11.00 target price on the biopharmaceutical company’s stock. Several other analysts have also recently weighed in on the company. Wells Fargo & Company began coverage on […] - 2025-02-11 06:58:48

MNKD institutional holdings

The following institutional investment holdings of MNKD have been identified

Date ETF ISIN/Name Num Shares Book value
2025-05-08 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 218,306USD 1,010,757
2025-05-08 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 101,894USD 471,769 -4.8%
2025-05-08 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 146,592USD 678,721
2025-05-08 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 146,592USD 678,721 -4.8%
2025-05-08 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 1,201USD 5,561 -4.7%
Total =614,585 USD 2,845,529
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.